Expression des epidermalen Wachstumsfaktorrezeptors Her2/neu in Rektumkarzinomen des lokal fortgeschrittenen Stadiums UICC II / III - Validierung an Patienten der Phase-III-Studien der German Rectal Cancer Study Group

Expression of the epidermal growth-factor-receptor Her2/neu in advanced local rectal cancer UICC II / III - validation on patients of the phase-III-studies of the german rectal cancer study group

by Marcus Storch
Doctoral thesis
Date of Examination:2016-09-28
Date of issue:2016-08-22
Advisor:Dr. Lena-Christin Conradi
Referee:Prof. Dr. Torsten Liersch
Referee:Prof. Dr. Peter Burfeind
Persistent Address: http://dx.doi.org/10.53846/goediss-5814

 

 

Files in this item

Name:Promotionsschrift - MStorch - ediss web.pdf
Size:2.95Mb
Format:PDF
Description:Dissertation

The following license files are associated with this item:

Abstract

English

Validation of the frequency of the expression of her2/neu in rectal cancer. Her2/neu is an epidermal growth factor receptor known from breast or oesophagus cancer and thought to be a possible therapy target in rectal cancer.
Keywords: rectal cancer; her2/neu; epidermal growth factor receptor; CAO/ARO/AIO-04; CAO/ARO/AIO-94
Schlagwörter: CAO/ARO/AIO-04; Rektumkarzinom; her2/neu; CAO/ARO/AIO-94
 
Statistik